VIVUS, Inc. (VVUS) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bearish

50% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 12/17/2014 1 week $3.20 $3.17 -0.94% 1 Active
Comments:
Biotech_Invest Biotech_Invest 11/21/2014 3 months $3.35 $3.17 -5.37% -5 Active
Comments: good entry pps for long-term investment, 2 FDA approved drugs = very strong acquisition target
Cezar, CFTe Cezar, CFTe 09/15/2014 3 months $3.90 $3.00 -23.08% 23 Ended
Comments: Mature Downtrend: too many oversold signals.
Randy_50 Randy_50 07/02/2013 3 months $12.58 $20.25 +60.97% -60 Ended
Comments: SELL VVUS now! heading back toward $7.00
06/16/2013 3 months $13.81 $10.12 -26.72% -26 Ended
Comments: Earnings 0.20%
JOKER66 JOKER66 04/19/2013 1 day $12.09 $20.25 +67.49% 67 Ended
Comments:
marcelo aniloel zampolli marcelo aniloel zampolli 03/08/2013 3 months $11.70 $14.17 +21.11% -21 Ended
Comments:
victory01 victory01 03/07/2013 3 months $11.43 $14.60 +27.73% 27 Ended
Comments:
4William 4William 11/21/2012 1 day $11.79 $11.43 -3.05% 3 Ended
Comments:
chriscat chriscat 07/01/2012 3 months $28.54 $17.82 -37.56% 37 Ended
Comments: stock allready has runup not much more room to go
Eventus Eventus 05/25/2012 3 months $24.67 $21.38 -13.34% -13 Ended
Comments: Upcoming product launch will be successful
Chris_158 Chris_158 03/13/2012 3 months $19.66 $24.45 +24.36% 24 Ended
Comments: I believe the FDA will approve...
Jim Brady Jim Brady 12/16/2010 3 months $9.48 $25.78 +171.89% 171 Ended
Comments: Upcoming product launch will be successful
WCoastGuynCA WCoastGuynCA 10/04/2010 1 Year $6.38 $25.78 +304% 303 Ended
Comments: Upcoming product launch will be successful
Prasad_2 Prasad_2 07/15/2010 3 months N/A Ended
Comments: ,
roncee_1 roncee_1 01/04/2010 3 months N/A Ended
Comments:

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.